TenNor Therapeutics

TenNor Therapeutics Overview

Founded 2013
Founded
Status Private
Latest Deal Type Series B
Latest Deal Amount $25M
Latest Deal Amount
Investors 8

TenNor Therapeutics General Information

Description

Provider oif a drug discovery platform designed to develop innovative drugs for infectious disease area. The company's platform offers a multi targeting, strong, globally protected product development portfolio for treating gastrointestinal tract infection, prosthetic joint infection, bacterial vaginosis , multidrug resistant tuberculosis, enabling users to get drugs that meet the unmet needs of treating different infectious diseases.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 218 Xinghu Street
  • Building B2, Room 711, Suzhou Industrial Park
  • Suzhou, 215123
  • China
+86 0512 0000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TenNor Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 19-Sep-2016 $25M 00.00 Completed Generating Revenue
2. Grant 01-Feb-2016 Completed Startup
1. Early Stage VC Completed Startup

TenNor Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Zhenkun Ma Ph.D Founder, Chief Executive Officer & Board Member
Emily Chen Director, Finance
Ying Yuan Ph.D Vice President, Biology
Xiaomei Wang Vice President, Clinical Operations

TenNor Therapeutics Board Members (6)

To view TenNor Therapeutics‘s full board member team, request access »
Name Representing Role Since
Allen Chao Ph.D Newport Healthcare Advisors Board Member 000 0000
Edward Hu Ph.D WuXi Healthcare Ventures Board Member 000 0000
Feng Deng Northern Light Venture Capital Board Member 000 0000
Lianyong Chen Ph.D Frontline BioVentures Board Member 000 0000
Morton Meyerson 2M Companies Board Member 000 0000

TenNor Therapeutics Investors (8)

To view TenNor Therapeutics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Frontline BioVentures Venture Capital Minority 000 0000 000000 0
Northern Light Venture Capital Venture Capital Minority 000 0000 000000 0
Oriza Holdings Fund of Funds Minority 000 0000 000000 0
Relativity Capital PE/Buyout Minority 000 0000 000000 0
WuXi Healthcare Ventures Corporate Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial